Yaw Bediako Recognized Among The 100 Most Influential CEOs in Oncology in 2025.
Yaw Bediako is an immunologist and the CEO of Yemaachi Biotech, an Accra-based immunogenomics company focused on diversifying precision oncology. Under his leadership, Yemaachi has positioned itself as a key contributor to African cancer research by leveraging the continent’s genetic diversity to identify novel biomarkers and therapeutic targets. A landmark achievement of his tenure is the 2025 launch […]
Building Biotechnology in Africa
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.